Highly rated in
Highly rated in
Check Dr. Basil T. Darras' experience treating your condition:
About Dr. Basil T. Darras

Basil Darras is a Neurologist and a Pediatrics expert in Boston, Massachusetts. Darras has been practicing medicine for over 45 years and is highly rated in 22 conditions, according to our data. His top areas of expertise are Spinal Muscular Atrophy SMA, Spinal Muscular Atrophy Type 1, Primary Lateral Sclerosis, Duchenne Muscular Dystrophy, and Spinal Fusion. He is licensed to treat patients in Massachusetts. Darras is currently accepting new patients.

His clinical research consists of co-authoring 175 peer reviewed articles and participating in 17 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Basil T. Darras it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Basil T. Darras accepts the following insurance:

  •  Ambetter
  •  Anthem

Call to see if your plan is accepted.
300 Longwood Ave, Boston, MA 02115
Background & Education
Graduate Institution
Other, 1977
Neurology with Special Qualifications in Neurology in MA
Hospital Affiliations
Brigham And Womens Hospital
Boston Childrens Hospital
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

17 Clinical Trials

Extracellular RNA Biomarkers of Duchenne Muscular Dystrophy
A Double-Blind, Placebo-Controlled, Multi-Center Study With an Open-Label Extension to Evaluate the Efficacy and Safety of SRP-4045 and SRP-4053 in Patients With Duchenne Muscular Dystrophy
A Prospective, Long-Term Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
A Phase 3b Study to Evaluate Higher Dose Nusinersen (BIIB058) in Patients With Spinal Muscular Atrophy Previously Treated With Risdiplam
Escalating Dose and Randomized, Controlled Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy
An Open-Label, Multi-Center, Study With a Concurrent Untreated Control Arm to Evaluate the Efficacy and Safety of Eteplirsen in Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Trial of Pamrevlumab (FG-3019), a Monoclonal Antibody to Connective Tissue Growth Factor, in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy
Phase 3, Open-Label, Single-Arm, Single-Dose Gene Replacement Therapy Clinical Trial for Patients With Spinal Muscular Atrophy Type 1 With One or Two SMN2 Copies Delivering AVXS-101 by Intravenous Infusion
Phase I, Open-Label, Dose Comparison Study of AVXS-101 for Sitting But Non-ambulatory Patients With Spinal Muscular Atrophy
View 12 Less Clinical Trials -

175 Total Publications

Spinal muscular atrophy.

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors